SINGULAIR® (Montelukast) is an oral tablet medicine used in the treatment of asthma
in adults and children (including exercise induced asthma) and asthma with
seasonal allergic rhinitis in adults.
This website is intended for healthcare professionals to find out more about the
clinical evidence behind SINGULAIR. If you have been prescribed SINGULAIR or you
are not a healthcare professional but would like to find out more information about
asthma or its symptoms, please click here.
If you are a healthcare professional, please enter your GMC or NMC number and
surname below to access the site.
|
| |
|
|
|
|
|
